Tempus AI has expanded its clinical oncology offerings with the launch of the ArteraAI Prostate Test for metastatic hormone-sensitive prostate cancer. This new tool integrates externally developed AI
Nobel Laureate Jennifer Doudna's team has developed an AI-powered platform to design novel gene-editing enzymes, creating synthetic RNA-guided nucleases (SynTnpBs) that rival or outperform natural cou
AI drug discovery startup Chai Discovery has secured $400 million in new funding, tripling its valuation to $3.8 billion in just seven months. The round was led by Index Ventures, with previous suppor
Axoft has successfully secured $55 million in an oversubscribed Series A funding round, led by C.P. Group Innovation. This capital will be used to expand global clinical trials and advance U.S. regula
South Korean AI company Lunit has joined a global consortium of eight companies specializing in AI, digital pathology, and precision diagnostics. The consortium aims to strengthen AI-based pathology a
Chai Discovery, an AI-enabled drug design company, has successfully closed a $400 million Series C financing round, bringing its valuation to $3.8 billion. This significant funding will support the co